A Phase I randomised, double-blind, parallel-group, placebo-controlled, multiple dose ascending study of CK 2127107 in healthy volunteers

Trial Profile

A Phase I randomised, double-blind, parallel-group, placebo-controlled, multiple dose ascending study of CK 2127107 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2015

At a glance

  • Drugs CK 2127107 (Primary)
  • Indications Muscular atrophy
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Cytokinetics
  • Most Recent Events

    • 19 Jun 2015 According to a Cytokinetics media release, results from this and two other studies (profiles 700242100 and 700247918) were presented at the 19th International SMA (Spinal Muscular Atrophy) Researcher Meeting held during the 2015 Annual SMA Conference.
    • 13 Oct 2014 Results published in the Media Release.
    • 13 Oct 2014 Status changed from recruiting to completed, according to a Cytokinetics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top